Abstract-This study investigates the role of extracellular signal-regulated kinases (ERKs) ] i (E max , 294Ϯ55 nmol/L) and pH i (E max , 7.27Ϯ0.04) effects were significantly reduced by PD98059 in SHR. Ang II-induced ERK activity was significantly greater (PϽ0.05) in SHR than in WKY. In conclusion, Ang II-stimulated signal transduction and associated VSMC contraction are enhanced in SHR. MAP/ERK inhibition abrogated sustained contraction and normalized Ang II effects in SHR. These data suggest that ERK-dependent signaling pathways influence contraction and that they play a role in vascular hyperresponsiveness in SHR. (Circ Res. 1999;84:505-515.) Key Words: [Ca 2ϩ ] i Ⅲ pH i Ⅲ resistance vessel Ⅲ PD98059 Ⅲ hypertension I ncreased peripheral resistance plays a critical role in blood pressure elevation. In spontaneously hypertensive rats (SHR), this increase in vascular resistance has been attributed to multiple interacting factors, including structural alterations in small vessels, decreased endothelium-dependent vasodilation, and enhanced vascular reactivity to vasoconstrictor stimuli. 1 Of the many vasoactive agonists that have been implicated in vascular hyperresponsiveness in hypertension, angiotensin II (Ang II) appears to play one of the most important roles. Whereas responses to endothelin-1, vasopressin, and norepinephrine have been reported to be decreased, unchanged, or (rarely) increased, vascular reactivity to Ang II has, for the most part, been found to be increased in vessels from adult SHR. 2-4 Altered Ang II-stimulated vascular responsiveness occurs early in the development of hypertension, and we and others have shown increased intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and contractile effects of Ang II in SHR as young as 6 weeks of age. 5,6 Ang IImediated vascular hyperresponsiveness is not specific to SHR, as similar Ang II-related actions, both in the prehypertensive and established hypertensive phases, have been demonstrated in other models of hypertension, including strokeprone SHR, renal hypertensive rats, and desoxycorticosterone acetate/salt-hypertensive rats. [7][8][9] The signal transduction systems responsible for enhanced Ang II-elicited excitation-contraction coupling in hypertension are not completely understood, and the signaling processes involved in the prehypertensive phase may differ from